OrbiMed Advisors
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- India
- China
- United States
Investment stages
- Seed
- Series A
- Series B
- Growth Equity
Industries
- Healthcare
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Medical Devices
About
Headquartered in San Francisco, United States, OrbiMed is one of the world’s largest healthcare investment firms. It manages diverse funds, including private equity, public equity, and credit vehicles, backing companies across biotech, pharma, and medtech.
Headquartered in San Francisco, United States, OrbiMed is one of the world’s largest healthcare investment firms. It manages diverse funds, including private equity, public equity, and credit vehicles, backing companies across biotech, pharma, and medtech.
Investment Thesis
OrbiMed Advisors operates a multi-stage investment strategy across healthcare, funding startups from seed to growth equity. Its thesis emphasizes advancing life sciences innovation globally, supporting companies that can significantly impact patient health.
Team
Samuel Isaly – Founder and Chairman Emeritus
Michael Sheffery – Founder and Chairman Emeritus
Arvind Desai – Founder and Chairman Emeritus
Carl L. Gordon – Managing Partner
Trey Block – Chief Financial Officer (CFO)
Sven H. Borho – Managing Partner
W. Carter Neild – Managing Partner
Alexander M. Cooper – General Counsel
Iain D. Dukes – Venture Partner
C. Scotland Stevens – General Partner
Michael Eggenberg – Partner
Doug Coon – Chief Compliance Officer
Mona Ashiya – Partner
Erez Chimovits – Partner
David Bonita – General Partner
Sevgi Gurkan – General Partner
Portfolio
AbCellera
Acelyrin
Acutus
Adaptive Biotechnologies
ADARx
SpringWorks
Treeline Biosciences